Atika Capital Management LLC Crispr Therapeutics Ag Call Options Transaction History

Atika Capital Management LLC

  • $841 Million
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$79.67 - $173.23 $2.79 Million - $6.06 Million
-35,000 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$78.5 - $100.64 $2.75 Million - $3.52 Million
35,000 New
35,000 $2.93 Million
Q4 2018

Feb 14, 2019
SELL
$22.73 - $42.34 $454,600 - $846,800
-20,000 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$42.62 - $73.59 $852,400 - $1.47 Million
20,000 New
20,000 $1.18 Million

Others Institutions Holding CRSP

# of Institutions
523
Shares Held
57.9M
Call Options Held
1.73M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.54B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email